Should Lilly Investors Worry About Its Rival From Within
Eli Lilly dominates the GLP-1 space, but competition is heating up from outside and inside its own lineup. This guide...
Enjoying retirement is vital for overall well-being and happiness. Discover the importance of savoring this special life stage.
20,466 articlesEli Lilly dominates the GLP-1 space, but competition is heating up from outside and inside its own lineup. This guide...
A stunning earnings moment has sparked questions about AMD's role in AI infrastructure. This deep-dive breaks down wh...
AMD posts a sharp rise in free cash flow as data center demand surges, while Intel bankrolls a costly foundry rebuild...
XRP rose near $1.28 as the CLARITY Act advanced in the Senate, rekindling bets on clearer crypto rules and possible i...
Qualcomm has vaulted from March lows as auto and IoT growth accelerates. Yet market skeptics linger, with hyperscaler...
AI-driven changes across industries are upending job security and prompting a reevaluation of savings. Analysts advoc...
Alumis stock over 300% has turned heads after a big healthcare investor trimmed its stake. This article breaks down w...
A new ADP study ranks metro areas for recent grads, and southern markets lead the way. The report shows hiring streng...
The CLARITY Act cleared the Senate Banking Committee, advancing a path toward floor consideration and a broader regul...
XRP faces a staged path to higher levels, with Standard Chartered outlining a first milestone near $4 before targetin...
KeyBanc boosted its outlook on CrowdStrike, lifting the price target to $700 after signals from the Mythos conference...
Tesla commands a large slug of XLY, giving the fund a distinct risk/reward profile compared with VCR. In the past fiv...